Publications
Ahles TA, Herndon JE, Small EJ, Vogelzang NJ, Kornblith AB, Ratain MJ, Stadler W, Palchak D, Marshall ME, Wilding G, Petrylak D, Holland JC, Cancer and Leukemia Group B. Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480. Cancer. 2004. PMID: 15484217
Tempero MA. Clinical oncology 2004: the president's report. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004. PMID: 15542796
Rini BI, Small EJ. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004. PMID: 15534359
Couriel D, Caldera H, Champlin R, Komanduri K. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer. 2004. PMID: 15372473
Bergsland EK. Update on clinical trials targeting vascular endothelial growth factor in cancer. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2004. PMID: 15552622
Bergsland EK. Vascular endothelial growth factor as a therapeutic target in cancer. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2004. PMID: 15552621
Goldberg RM, Venook AP, Schilsky RL. Cetuximab in the treatment of colorectal cancer. Clinical advances in hematology & oncology : H&O. 2004. PMID: 16170891
Martinez-Mariño B, Shiboski S, Hecht FM, Kahn JO, Levy JA. Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART. AIDS (London, England). 2004. PMID: 15577620
Levy JA. Prospects for an AIDS vaccine: encourage innate immunity. AIDS (London, England). 2004. PMID: 15577631
Wang H, McCann FE, Gordan JD, Wu X, Raab M, Malik TH, Davis DM, Rudd CE. ADAP-SLP-76 binding differentially regulates supramolecular activation cluster (SMAC) formation relative to T cell-APC conjugation. The Journal of experimental medicine. 2004. PMID: 15477347
Petrylak DP, Tangen CM, Hussain MH, Lara PN, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. The New England journal of medicine. 2004. PMID: 15470214
Logan AC, Nightingale SJ, Haas DL, Cho GJ, Pepper KA, Kohn DB. Factors influencing the titer and infectivity of lentiviral vectors. Human gene therapy. 2004. PMID: 15585113
Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Molecular and cellular biology. 2004. PMID: 15367669
Turner N, Tutt A, Ashworth A. Hallmarks of 'BRCAness' in sporadic cancers. Nature reviews. Cancer. 2004. PMID: 15510162
Allen GM, Shortall BP, Gemci T, Corcoran TE, Chigier NA. Computational simulations of airflow in an in vitro model of the pediatric upper airways. Journal of biomechanical engineering. 2004. PMID: 15648813
Tindall D, Horne FM, Hruszkewycz A, Mohla S, Shuman M, Wang Z, Kantoff P. Symposium on androgen action in prostate cancer. Cancer research. 2004. PMID: 15466216
Allen J, Bergsland EK. Angiogenesis in colorectal cancer: therapeutic implications and future directions. Hematology/oncology clinics of North America. 2004. PMID: 15474337
Smith MR, Manola J, Kaufman DS, George D, Oh WK, Mueller E, Slovin S, Spiegelman B, Small E, Kantoff PW. Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy. Cancer. 2004. PMID: 15468186
Whisenant J, Venook A. Regional therapy of liver metastases. Current treatment options in oncology. 2004. PMID: 15341680
Logan AC, Nightingale SJ, Haas DL, Cho GJ, Pepper KA, Kohn DB. Factors influencing the titer and infectivity of lentiviral vectors. Human gene therapy. 2004. PMID: 15585113